OMAR Opioid Use Disorder
Key facts
- Who runs it
- Yale University
- Where
- New Haven, United StatesSee the site
- Trial code
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 30 people, planned
- Started
- 10 Mar 2023
- Expected to end
- 15 Dec 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- [11C]OMAR
- Record updated
- 10 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (10)Hide the full registry criteria
Who can take part
- Able to provide informed consent
- Male and female 18 years and older
- DSM-5 diagnosis of opioid use disorder (for OUD group)
- Physically healthy i.e., no clinically unstable medical conditions
- Written informed consent and have capacity to consent and comply with study procedures
Who cannot take part
- Have had exposure to ionizing radiation that in combination with the study tracer would result in a cumulative exposure that exceeds recommended exposure limits
- Current neuro-psychiatric illness or severe systemic disease (opioid use disorder is permitted in the OUD group)
- Presence of ferromagnetic metal in the body or heart pacemaker
- Are claustrophobic
- Hematocrit values lower than 30
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Opioid use disorder
This trial is currently available in United States.
- Connecticut Mental Health Center, Clinical Neuroscience Research UnitNew Haven, United StatesContact: Abby DeweyTaking people
About the trial
What the trial wants to find out
The goal of this research study is to examine the endocannabinoid (eCB) function in vivo in individuals with opioid use disorder (OUD) by measuring cannabinoid receptor 1 (CB1R) availability.
The 2 groups in the trial
- Healthy VolunteersOther group
Healthy volunteers with no current or past major medical or psychiatric history
Treatment: [11C]OMAR
- Opioid Use DisorderOther group
Patients diagnosed with opioid use disorder
Treatment: [11C]OMAR
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Characterization of CB1 Receptors Using [11-C]OMAR in Opioid Use Disorder
- Criteria questions
- Built from NCT05683184, who can take part
- Record updated
- 10 September 2026